eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Novo Nordisk - Comment

Novo Nordisk - Comment

Document ID: FDA-2012-D-0523-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 24 2012, at 12:00 AM Eastern Daylight Time
Date Posted: October 2 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: August 13 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: September 27 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 811250c1
View Document:  View as format xml

View Comment

Please see attached file

Attachments:

Novo Nordisk Inc Comment on Draft Guidance for Industry and FDA 510K Refuse to Accept Policy

Title:
Novo Nordisk Inc Comment on Draft Guidance for Industry and FDA 510K Refuse to Accept Policy

View Attachment: View as format pdf

Related Comments

    View All
Total: 7
Rosina Robinson, RN, MEd, RAC - Comment
Public Submission    Posted: 09/06/2012     ID: FDA-2012-D-0523-0003

Sep 27,2012 11:59 PM ET
Novo Nordisk - Comment
Public Submission    Posted: 10/02/2012     ID: FDA-2012-D-0523-0006

Sep 27,2012 11:59 PM ET
Abbott Laboratories - Comment
Public Submission    Posted: 10/02/2012     ID: FDA-2012-D-0523-0007

Sep 27,2012 11:59 PM ET
Advanced Medical Technology Association (AdvaMed) - Comment
Public Submission    Posted: 10/02/2012     ID: FDA-2012-D-0523-0008

Sep 27,2012 11:59 PM ET
Orthopedic Surgical Manufacturers Association (OSMA) - Comment
Public Submission    Posted: 10/02/2012     ID: FDA-2012-D-0523-0009

Sep 27,2012 11:59 PM ET